Nocebo effects in the treatment of endometriosis.

Reproduction & Fertility Pub Date : 2021-09-23 eCollection Date: 2021-12-01 DOI:10.1530/RAF-21-0040
Peter Thiel, Matthew J Burke, Philippa Bridge-Cook, Mathew Leonardi
{"title":"Nocebo effects in the treatment of endometriosis.","authors":"Peter Thiel,&nbsp;Matthew J Burke,&nbsp;Philippa Bridge-Cook,&nbsp;Mathew Leonardi","doi":"10.1530/RAF-21-0040","DOIUrl":null,"url":null,"abstract":"<p><p>The current approach to treating endometriosis is often inadequate or intolerable for many patients. Until more effective therapies are available, we should aim to maximize the effectiveness of our current options. Optimization may be possible by reducing nocebo effects, which are the negative therapeutic effects not directly caused by a treatment. Awareness of these effects, how they arise, and the factors influencing them, is invaluable if we aim to limit their magnitude. The unique nature of endometriosis diagnosis and management is especially prone to nocebo effects due to multiple factors, including diagnostic delays, feelings of invalidation, social transmission of expectations, and persistent symptoms despite numerous treatments. This commentary discusses the origins of these effects in people with endometriosis, methods of limiting nocebo effects, and future research directions.</p><p><strong>Lay summary: </strong>The term 'nocebo' describes the undesirable effects of a medication or treatment that patients may experience which are not directly caused by the treatment (e.g. tiredness from a sugar pill). These arise from pre-existing expectations toward a treatment and are influenced by multiple external factors, including past experiences, online media, personal beliefs, and personality factors. Endometriosis is a disease characterized by cells like those from the inside of the uterus growing outside of the uterus. The complex nature of endometriosis diagnosis and management creates an environment where nocebo effects may affect treatment outcomes. We may be able to limit nocebo effects through awareness and simple actions that strengthen patient-doctor relationships. Effective therapeutic relationships with doctors are crucial in limiting negative expectations and are established through empathy, honesty, and support. Therapeutic relationships built on trust may allow healthcare providers to address negative expectations, nocebo effects, and the misinformation affecting endometriosis management.</p>","PeriodicalId":21128,"journal":{"name":"Reproduction & Fertility","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801028/pdf/","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reproduction & Fertility","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1530/RAF-21-0040","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/12/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

The current approach to treating endometriosis is often inadequate or intolerable for many patients. Until more effective therapies are available, we should aim to maximize the effectiveness of our current options. Optimization may be possible by reducing nocebo effects, which are the negative therapeutic effects not directly caused by a treatment. Awareness of these effects, how they arise, and the factors influencing them, is invaluable if we aim to limit their magnitude. The unique nature of endometriosis diagnosis and management is especially prone to nocebo effects due to multiple factors, including diagnostic delays, feelings of invalidation, social transmission of expectations, and persistent symptoms despite numerous treatments. This commentary discusses the origins of these effects in people with endometriosis, methods of limiting nocebo effects, and future research directions.

Lay summary: The term 'nocebo' describes the undesirable effects of a medication or treatment that patients may experience which are not directly caused by the treatment (e.g. tiredness from a sugar pill). These arise from pre-existing expectations toward a treatment and are influenced by multiple external factors, including past experiences, online media, personal beliefs, and personality factors. Endometriosis is a disease characterized by cells like those from the inside of the uterus growing outside of the uterus. The complex nature of endometriosis diagnosis and management creates an environment where nocebo effects may affect treatment outcomes. We may be able to limit nocebo effects through awareness and simple actions that strengthen patient-doctor relationships. Effective therapeutic relationships with doctors are crucial in limiting negative expectations and are established through empathy, honesty, and support. Therapeutic relationships built on trust may allow healthcare providers to address negative expectations, nocebo effects, and the misinformation affecting endometriosis management.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
反安慰剂在子宫内膜异位症治疗中的作用。
目前治疗子宫内膜异位症的方法对许多患者来说往往是不充分的或无法忍受的。在更有效的治疗方法出现之前,我们的目标应该是最大限度地提高现有选择的有效性。通过减少反安慰剂效应,即非直接由治疗引起的负面治疗效应,可能实现优化。如果我们的目标是限制这些影响的程度,那么了解这些影响、它们是如何产生的以及影响它们的因素是非常宝贵的。由于多种因素,子宫内膜异位症的诊断和治疗的独特性质特别容易产生反安慰剂效应,包括诊断延迟、感觉无效、期望的社会传递以及尽管进行了多次治疗,但症状仍持续存在。这篇评论讨论了子宫内膜异位症患者这些效应的起源、限制反安慰剂效应的方法以及未来的研究方向。总结:“反安慰剂”一词描述了一种药物或治疗的不良影响,这种不良影响可能不是由治疗直接引起的(例如,糖丸引起的疲劳)。这些源于对治疗预先存在的期望,并受到多种外部因素的影响,包括过去的经历、网络媒体、个人信仰和个性因素。子宫内膜异位症是一种疾病,其特征是来自子宫内部的细胞在子宫外生长。子宫内膜异位症诊断和治疗的复杂性创造了反安慰剂效应可能影响治疗结果的环境。我们也许可以通过意识和简单的行动来限制反安慰剂效应,加强医患关系。与医生建立有效的治疗关系对于限制负面期望至关重要,并通过移情、诚实和支持来建立。建立在信任基础上的治疗关系可以让医疗保健提供者解决负面预期、反安慰剂效应和影响子宫内膜异位症管理的错误信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The (cost-) effectiveness Of Surgical excision of Colorectal endometriosis compared to ART treatment trAjectory (TOSCA study) - a study protocol. Quality of fresh and cryopreserved bovine sperm is reduced by BPA and BPF exposure. Presence of KREMEN receptors for DKK1 in the preimplantation bovine embryo. Role of oxidative stress in male infertility. Impact of vitamin B12 on the reproductive health of women with sickle cell disease: a narrative review.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1